Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
NLTX: Stock Quote & Summary Data
1.06%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 28,816 |
| Previous Close | $ 1.516 |
| 52 Wk High / Low | $ 2.30 / $ 0.25 |
| Shares Outstanding | 27,032,000 |
| Market Value | $ 40,548,000 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.91 |
| NASDAQ Official Open Price: | $ 1.40 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 1.50 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About NLTX?
Ask your question about about Nile Therapeutics, Inc. (NLTX) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a development stage biopharmaceutical company in the business of commercially developing innovative products for the treatment of cardiovascular diseases. Our lead compound is CD-NP, a chimeric natriuretic peptide currently in Phase I clinical studies for the treatment of heart failure. We believe CD-NP may be useful in several cardiovascular and renal indications. We are initially developing CD-NP as a treatment for heart failure. We are also developing 2NTX-99, a pre-clinical, small molecule, anti-atherothrombotic agent with nitric oxide (NO) donating properties. We were incorporated in the State of Nevada on June 17, 1996 and reincorporated in Delaware on February 9, 2007, at which time our name was SMI Products, Inc., or SMI. From inception through August 11, 2006, SMI was a development stage company in the business of internet real estate mortgage services. On and after August 11, 2006, SMI ceased its prior business. ... More ...
Links to all Nile Therapeutics, Inc. (NLTX) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for NLTX |
||
|
Nile Therapeutics Q3 Loss Narrows - Quick Facts - RTT News 11/12/2009 5:40PM |
||
|
Nile Therapeutics Reports 2009 Third Quarter Financial Results - Business Wire 11/12/2009 5:00PM |
||
|
Nile Therapeutics Appoints Arie S. Belldegrun, M.D., to Board of Directors - PR Newswire 09/29/2009 7:00AM |
||
|
Nile Therapeutics Appoints Frank Litvack, M.D., to Board of Directors - PR Newswire 09/25/2009 7:00AM |
||
|
Nile Therapeutics Announces Poster Presentation at 2009 Heart Failure Society of America Annual Meeting - PR Newswire 09/14/2009 8:51AM |
||
|
Nile Therapeutics Q2 Loss Narrows As Expenses Decline - Update - RTT News 08/13/2009 12:25PM |
||
|
Nile Therapeutics Posts Narrower, Yet Wider-than-estimated Q2 Loss - Quick Facts - RTT News 08/13/2009 9:16AM |
